These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7223593)

  • 1. Beneficial hemodynamic response to chronic prazosin therapy in congestive heart failure.
    Feldman RC; Ball RM; Winchester MA; Jaillon P; Kates RE; Harrison DC
    Am Heart J; 1981 May; 101(5):534-40. PubMed ID: 7223593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of prazosin effect on cardiac output in chronic heart failure.
    Arnold SB; Williams RL; Ports TA; Baughman RA; Benet LZ; Parmley WW; Chatterjee K
    Ann Intern Med; 1979 Sep; 91(3):345-9. PubMed ID: 475164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of pharmacodynamic tolerance to prozosin in congestive heart failure.
    Desch CE; Magorien RD; Triffon DW; Blanford MF; Unverferth DV; Leier CV
    Am J Cardiol; 1979 Nov; 44(6):1178-82. PubMed ID: 495512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The acute and chronic haemodynamic effects of prazosin in severe congestive cardiac failure.
    Harper RW; Claxton H; Middlebrook K; Anderson S; Pitt A
    Med J Aust; 1980 Jul; 2(SP1):36-8. PubMed ID: 7421721
    [No Abstract]   [Full Text] [Related]  

  • 5. Sustained effectiveness of chronic prazosin therapy in severe chronic congestive heart failure.
    Bertel O; Burkart F; Bühler FR
    Am Heart J; 1981 May; 101(5):529-33. PubMed ID: 7223592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the vasodilator prazosin and the selective beta1 agonist prenalterol on rest and exercise haemodynamics in CHF.
    Hutton I; Tweddel AC; Bastian BC; Murray RG
    Acta Med Scand Suppl; 1981; 652():163-8. PubMed ID: 6120615
    [No Abstract]   [Full Text] [Related]  

  • 7. Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin.
    Miller RR; Awan NA; Maxwell KS; Mason DT
    N Engl J Med; 1977 Aug; 297(6):303-7. PubMed ID: 889599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sustained and beneficial hemodynamic effects of prazosin in cardiac insufficiency].
    Harrison DC; Feldman RC; Ball RM
    Cardiology; 1980; 66 Suppl 2():162-8. PubMed ID: 6456814
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative hemodynamic effects of intravenous nitroprusside and oral prazosin in refractory heart failure.
    Mehta J; Iacona M; Feldman RL; Pepine CJ; Conti CR
    Am J Cardiol; 1978 May; 41(5):925-30. PubMed ID: 645603
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, hemodynamics and echocardiography.
    Awan NA; Miller RR; DeMaria AN; Maxwell KS; Neumann A; Mason DT
    Circulation; 1977 Sep; 56(3):346-54. PubMed ID: 884789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic application of prazosin in chronic refractory congestive heart failure. Tolerance and "tachyphylaxis" in perspective.
    Awan NA; Needham KE; Evenson MK; Amsterdam EE; Mason DT
    Am J Med; 1981 Jul; 71(1):153-60. PubMed ID: 7246573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodynamic effects of prazosin in CHF.
    Reuben SR; Kuan P; Gale EV; Wilde PM
    Acta Med Scand Suppl; 1981; 652():145-8. PubMed ID: 6949460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prazosin in the treatment of chronic cardiac insufficiency].
    Champoud O; Cribier A; Letac B
    Ann Med Interne (Paris); 1985; 136(3):261-5. PubMed ID: 2862824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic responses to continuous use of prazosin and hydralazine in patients with refractory heart failure.
    Elkayam U; Mathur M; Frishman W; LeJemtel T; Strom J; Sonnenblick EH
    Clin Pharmacol Ther; 1981 Jul; 30(1):23-30. PubMed ID: 7237894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-invasive radiocardiographic assessment of the effects of prazosin in congestive heart failure.
    Nakajima H; Yui Y; Kawashita K; Yoshida A; Kawai C
    Jpn Circ J; 1982 May; 46(5):468-72. PubMed ID: 7077811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prazosin and hydralazine in congestive heart failure. Regional hemodynamic effects in relation to dose.
    Magorien RD; Triffon DW; Desch CE; Bay WH; Unverferth DV; Leier CV
    Ann Intern Med; 1981 Jul; 95(1):5-13. PubMed ID: 7247126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of prostacyclin and prazosin in the treatment of congestive heart failure; with special reference to the sympathetic nervous system.
    Yui Y; Sakurai T; Nakajima H; Kawai C
    Jpn Circ J; 1984 Apr; 48(4):365-72. PubMed ID: 6371282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic and hormonal effects of high-dose transdermal nitroglycerin in patients with chronic congestive heart failure.
    Elkayam U; Roth A; Henriquez B; Weber L; Tonnemacher D; Rahimtoola SH
    Am J Cardiol; 1985 Sep; 56(8):555-9. PubMed ID: 3929585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute and chronic haemodynamic effects of prazosin in left ventricular failure.
    Stein L; Foster PR; Friedman AW; Statza J; McHenry PL
    Br Heart J; 1981 Feb; 45(2):186-92. PubMed ID: 7459177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marked early attenuation of hemodynamic effects of oral prazosin therapy in chronic congestive heart failure.
    Elkayam U; Lejemtel TH; Mathur M; Ribner HS; Frishman WH; Strom J; Sonnenblick EH
    Am J Cardiol; 1979 Sep; 44(3):540-5. PubMed ID: 474434
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.